Cobio Diagnostics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $249K

  • Investors
  • 2

Cobio Diagnostics General Information

Description

Operator of a biotechnology company intended for rapid bacterial identification and antibiotic susceptibility tests. The company's technology utilizes a phage-based immunoassay to directly identify specific bacterial species and determine the effective course of antibiotic treatment and targeted alternative to traditional diagnostic techniques, enabling healthcare providers to make quicker and informed decisions about antibiotic use for patients with bacterial infections.

Contact Information

Website
www.cobio.co
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 219
  • Aurora, CO 80045
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 12635 East Montview Boulevard
  • Suite 219
  • Aurora, CO 80045
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cobio Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 16-Nov-2023 $249K Completed Generating Revenue
3. Accelerator/Incubator 01-Jul-2021 Completed Generating Revenue
2. Grant 17-Sep-2020 $251K $275K Completed Startup
1. Angel (individual) 20-Mar-2018 $275K $275K Completed Startup
To view Cobio Diagnostics’s complete valuation and funding history, request access »

Cobio Diagnostics Patents

Cobio Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260219269-A1 Kit for identifying antimicrobial agents and effective concentrations thereof Pending 08-Mar-2021
AU-2022232903-A1 Method and kit for identifying antimicrobial agents and effective concentrations thereof Active 08-Mar-2021
CA-3211336-A1 Method and kit for identifying antimicrobial agents and effective concentrations thereof Pending 08-Mar-2021
EP-4305423-A1 Method and kit for identifying antimicrobial agents and effective concentrations thereof Pending 08-Mar-2021
EP-4305423-A4 Method and kit for identifying antimicrobial agents and effective concentrations thereof Pending 08-Mar-2021 G01N33/56916
To view Cobio Diagnostics’s complete patent history, request access »

Cobio Diagnostics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced Industries Accelerator Government
US National Science Foundation Accelerator/Incubator Minority
To view Cobio Diagnostics’s complete investors history, request access »

Cobio Diagnostics FAQs

  • When was Cobio Diagnostics founded?

    Cobio Diagnostics was founded in 2016.

  • Where is Cobio Diagnostics headquartered?

    Cobio Diagnostics is headquartered in Aurora, CO.

  • What industry is Cobio Diagnostics in?

    Cobio Diagnostics’s primary industry is Drug Discovery.

  • Is Cobio Diagnostics a private or public company?

    Cobio Diagnostics is a Private company.

  • What is Cobio Diagnostics’s current revenue?

    The current revenue for Cobio Diagnostics is .

  • How much funding has Cobio Diagnostics raised over time?

    Cobio Diagnostics has raised $275K.

  • Who are Cobio Diagnostics’s investors?

    Advanced Industries Accelerator and US National Science Foundation have invested in Cobio Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process